Literature DB >> 21647587

Assessment of pituitary adenoma volumetric change using longitudinal MR image registration.

Geir Andre Ringstad1, Kyrre Eeg Emblem, Dominic Holland, Anders M Dale, Atle Bjornerud, John K Hald.   

Abstract

INTRODUCTION: Change detection is a crucial factor in monitoring of slowly evolving pathologies. The objective of the study was to test a semi-automatic method applied on longitudinal MRI monitoring of volume change in pituitary macroadenomas.
METHODS: The proposed method is based on a visual comparison of geometrically corrected, co-registered, intensity-normalized contrast-enhanced (CE) 3D GRE T1-weighted images. Qualitative volume changes based on this applied method were compared with experts' readings of conventional pre- and post-CE 2D T1-weighted images. Magnetic resonance (MR) imaging was performed two to four times in 13 patients with a total combination of 29 time points.
RESULTS: Compared to conventional 2D MR readings, a diagnosis of tumor growth (yes/no) was changed in 5 of 13 patients (38%) at 9 of the 29 combinations of time points (31%) using the 3D-based semi-automatic method. With manual tumor tracings as reference, McNemar's test showed a significant difference between the two methods.
CONCLUSION: Visual comparison of geometrically corrected, intensity-normalized, and affine-aligned longitudinal 3D images may enable more accurate assessment of qualitative volumetric change in pituitary adenomas than conventional reading of 2D images.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21647587     DOI: 10.1007/s00234-011-0894-7

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  24 in total

1.  Comparison of diameter and perimeter methods for tumor volume calculation.

Authors:  A G Sorensen; S Patel; C Harmath; S Bridges; J Synnott; A Sievers; Y H Yoon; E J Lee; M C Yang; R F Lewis; G J Harris; M Lev; P W Schaefer; B R Buchbinder; G Barest; K Yamada; J Ponzo; H Y Kwon; J Gemmete; J Farkas; A L Tievsky; R B Ziegler; M R Salhus; R Weisskoff
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

2.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

Review 3.  Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly.

Authors:  John S Bevan
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

4.  Subregional neuroanatomical change as a biomarker for Alzheimer's disease.

Authors:  Dominic Holland; James B Brewer; Donald J Hagler; Christine Fennema-Notestine; Christine Fenema-Notestine; Anders M Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-08       Impact factor: 11.205

5.  Long-acting somatostatin analog therapy of acromegaly: a meta-analysis.

Authors:  Pamela U Freda; Laurence Katznelson; Aart Jan van der Lely; Carlos M Reyes; Shouhao Zhao; Daniel Rabinowitz
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

6.  Nonlinear registration of longitudinal images and measurement of change in regions of interest.

Authors:  Dominic Holland; Anders M Dale
Journal:  Med Image Anal       Date:  2011-02-23       Impact factor: 8.545

7.  Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth.

Authors:  Y Greenman; G Ouaknine; I Veshchev; I I Reider-Groswasser; Y Segev; N Stern
Journal:  Clin Endocrinol (Oxf)       Date:  2003-06       Impact factor: 3.478

8.  Reliability of tumor volume estimation from MR images in patients with malignant glioma. Results from the American College of Radiology Imaging Network (ACRIN) 6662 Trial.

Authors:  Birgit B Ertl-Wagner; Jeffrey D Blume; Donald Peck; Jayaram K Udupa; Benjamin Herman; Anthony Levering; Ilona M Schmalfuss
Journal:  Eur Radiol       Date:  2008-10-17       Impact factor: 5.315

9.  Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas.

Authors:  A Colao; G Cerbone; P Cappabianca; D Ferone; A Alfieri; F Di Salle; A Faggiano; B Merola; E de Divitiis; G Lombardi
Journal:  J Endocrinol Invest       Date:  1998-05       Impact factor: 4.256

10.  Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking.

Authors:  Marco Losa; Micol Valle; Pietro Mortini; Alberto Franzin; Camillo Ferrari da Passano; Marco Cenzato; Stefania Bianchi; Piero Picozzi; Massimo Giovanelli
Journal:  J Neurosurg       Date:  2004-03       Impact factor: 5.115

View more
  1 in total

1.  Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up.

Authors:  Kristin Astrid Øystese; Manuela Zucknick; Olivera Casar-Borota; Geir Ringstad; Jens Bollerslev
Journal:  Endocrine       Date:  2017-05-17       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.